| Title |
Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2010
|
| DOI | 10.1002/14651858.cd000025.pub2 |
| Pubmed ID | |
| Authors |
Lelia Duley, A Metin Gülmezoglu, David J Henderson‐Smart, Doris Chou |
| Abstract |
Eclampsia, the occurrence of a seizure (fit) in association with pre-eclampsia, is rare but potentially life-threatening. Magnesium sulphate is the drug of choice for treating eclampsia. This review assesses its use for preventing eclampsia. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 2 | 18% |
| Colombia | 1 | 9% |
| United Kingdom | 1 | 9% |
| Spain | 1 | 9% |
| Portugal | 1 | 9% |
| Unknown | 5 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 91% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 545 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 2 | <1% |
| United Kingdom | 2 | <1% |
| United States | 2 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Ethiopia | 1 | <1% |
| Egypt | 1 | <1% |
| New Zealand | 1 | <1% |
| Unknown | 534 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 76 | 14% |
| Student > Bachelor | 76 | 14% |
| Researcher | 56 | 10% |
| Student > Postgraduate | 42 | 8% |
| Student > Ph. D. Student | 37 | 7% |
| Other | 110 | 20% |
| Unknown | 148 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 235 | 43% |
| Nursing and Health Professions | 39 | 7% |
| Social Sciences | 23 | 4% |
| Agricultural and Biological Sciences | 17 | 3% |
| Biochemistry, Genetics and Molecular Biology | 15 | 3% |
| Other | 57 | 10% |
| Unknown | 159 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 84. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#510,422
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#897
of 11,499 outputs
Outputs of similar age
#1,427
of 111,030 outputs
Outputs of similar age from Cochrane database of systematic reviews
#6
of 89 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,030 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.